Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren A Kaplan

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Plos One|October 8, 2013
The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysisWarren A Kaplan, Veronika J Wirtz, Peter Stephens
The International Journal of Health Planning and Management|September 14, 2018
Is Taiwan's National Health Insurance a perfect system? Problems related to health care utilization of the aboriginal population in rural townshipsYi-Ting Lee, Yen-Han Lee, Warren A Kaplan
Health Policy and Planning|March 16, 2016
Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12Abhishek Sharma, Warren A Kaplan, Maulik Chokshi, et al.
Plos One|February 25, 2016
Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?Reed F Beall, Jason W Nickerson, Warren A Kaplan, et al.
Health Policy (Amsterdam, Netherlands)|June 15, 2012
Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010Warren A Kaplan, Lindsay Sarah Ritz, Marie Vitello, et al.
Lancet (London, England)|July 23, 2013
Measuring universities' commitments to global healthVeronika J Wirtz, Taryn Vian, Warren A Kaplan, et al.
Trends in Biotechnology|September 18, 2018
The Open Insulin Project: A Case Study for 'Biohacked' MedicinesJenna E Gallegos, Christopher Boyer, Eleanore Pauwels, et al.
Circulation|October 5, 2016
Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries"Veronika J Wirtz, Warren A Kaplan, Gene F Kwan, et al.
Journal of Pharmaceutical Policy and Practice|May 20, 2017
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesWarren A Kaplan, Paul G Ashigbie, Mohamad I Brooks, et al.
Circulation|May 25, 2016
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesVeronika J Wirtz, Warren A Kaplan, Gene F Kwan, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Plos One|October 8, 2013
The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysisWarren A Kaplan, Veronika J Wirtz, Peter Stephens
The International Journal of Health Planning and Management|September 14, 2018
Is Taiwan's National Health Insurance a perfect system? Problems related to health care utilization of the aboriginal population in rural townshipsYi-Ting Lee, Yen-Han Lee, Warren A Kaplan
Health Policy and Planning|March 16, 2016
Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12Abhishek Sharma, Warren A Kaplan, Maulik Chokshi, et al.
Plos One|February 25, 2016
Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?Reed F Beall, Jason W Nickerson, Warren A Kaplan, et al.
Health Policy (Amsterdam, Netherlands)|June 15, 2012
Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010Warren A Kaplan, Lindsay Sarah Ritz, Marie Vitello, et al.
Lancet (London, England)|July 23, 2013
Measuring universities' commitments to global healthVeronika J Wirtz, Taryn Vian, Warren A Kaplan, et al.
Trends in Biotechnology|September 18, 2018
The Open Insulin Project: A Case Study for 'Biohacked' MedicinesJenna E Gallegos, Christopher Boyer, Eleanore Pauwels, et al.
Circulation|October 5, 2016
Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries"Veronika J Wirtz, Warren A Kaplan, Gene F Kwan, et al.
Journal of Pharmaceutical Policy and Practice|May 20, 2017
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studiesWarren A Kaplan, Paul G Ashigbie, Mohamad I Brooks, et al.
Circulation|May 25, 2016
Access to Medications for Cardiovascular Diseases in Low- and Middle-Income CountriesVeronika J Wirtz, Warren A Kaplan, Gene F Kwan, et al.
Pageof 4